← Back
Data updated: Mar 10, 2026
FOUGERA PHARMS
DermatologyOphthalmologyInfectious Disease
FOUGERA PHARMS is a pharmaceutical company focused on Dermatology, Ophthalmology, Infectious Disease.
1953
Since
50
Drugs
-
Trials
206
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
MUPIROCIN 2026-02-24
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
LIDOCAINE 2026-02-09
NYSTATIN 2026-02-05
BETAMETHASONE DIPROPIONATE 2026-01-26
ACYCLOVIR 2026-01-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 38%
3 drugs
Ophthalmology 25%
2 drugs
Infectious Disease 13%
1 drugs
Oncology 13%
1 drugs
Cardiovascular 13%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology, Ophthalmology
Bayer big-pharma
Oncology, Cardiovascular, Ophthalmology, Dermatology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
Active (25)
ADAPALENE IMIQUIMOD TACROLIMUS CALCIPOTRIENE PREDNICARBATE ALCLOMETASONE DIPROPIONATE FLUTICASONE PROPIONATE MUPIROCIN CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE KETOCONAZOLE HYDROCORTISONE VALERATE DESOXIMETASONE CICLOPIROX ACYCLOVIR CLOTRIMAZOLE FLUOCINONIDE EMULSIFIED BASE OXISTAT CLINDAMYCIN PHOSPHATE BETAMETHASONE DIPROPIONATE NITROGLYCERIN TYZINE NYSTATIN FLUOCINONIDE ERYTHROMYCIN SULFACETAMIDE SODIUM
Discontinued (24)
METRONIDAZOLE LIDOCAINE MOMETASONE FUROATE TAZAROTENE CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE FLUOCINOLONE ACETONIDE TERCONAZOLE HYDROCORTISONE LIDOCAINE AND PRILOCAINE SOLARAZE BETAMETHASONE VALERATE GENTAMICIN SULFATE DESONIDE NYSTATIN AND TRIAMCINOLONE ACETONIDE CUTIVATE CLOBETASOL PROPIONATE (EMOLLIENT) TEMOVATE E ACLOVATE PAMINE FORTE PAMINE TEMOVATE C-SOLVE-2 CARMOL HC
Company Info
- First Approval
- 1953-04-09
- Latest
- 2026-02-24
- Applications
- 105
FDA Sponsor Names
FOUGERA PHARMSFOUGERA PHARMS INC